Cargando…

Nanomedicine and Onco-Immunotherapy: From the Bench to Bedside to Biomarkers

The broad relationship between the immune system and cancer is opening a new hallmark to explore for nanomedicine. Here, all the common and synergy points between both areas are reviewed and described, and the recent approaches which show the progress from the bench to the beside to biomarkers devel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Acebes-Fernández, Vanessa, Landeira-Viñuela, Alicia, Juanes-Velasco, Pablo, Hernández, Angela-Patricia, Otazo-Perez, Andrea, Manzano-Román, Raúl, Gongora, Rafael, Fuentes, Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407304/ https://www.ncbi.nlm.nih.gov/pubmed/32610601 http://dx.doi.org/10.3390/nano10071274

Ejemplares similares

Interactions of Nanoparticles and Biosystems: Microenvironment of Nanoparticles and Biomolecules in Nanomedicine
por: Auría-Soro, Carlota, et al.
Publicado: (2019)

Restoring the Immunity in the Tumor Microenvironment: Insights into Immunogenic Cell Death in Onco-Therapies
por: Hernández, Ángela-Patricia, et al.
Publicado: (2021)

Deciphering Human Leukocyte Antigen Susceptibility Maps From Immunopeptidomics Characterization in Oncology and Infections
por: Juanes-Velasco, Pablo, et al.
Publicado: (2021)

Promoting the bench-to-bedside translation of nanomedicines
por: Zhang, Ning
Publicado: (2023)

Single-Cell Proteomics: The Critical Role of Nanotechnology
por: Arias-Hidalgo, Carlota, et al.
Publicado: (2022)

Externally-Controlled Systems for Immunotherapy: From Bench to Bedside
por: Tristán-Manzano, María, et al.
Publicado: (2020)

The OncoAge Consortium: Linking Aging and Oncology from Bench to Bedside and Back Again
por: Hofman, Paul, et al.
Publicado: (2019)

Autoimmune Responses in Oncology: Causes and Significance
por: Bareke, Halin, et al.
Publicado: (2021)

Deepening into Intracellular Signaling Landscape through Integrative Spatial Proteomics and Transcriptomics in a Lymphoma Model
por: Landeira-Viñuela, Alicia, et al.
Publicado: (2021)

Detection of Human p53 In-Vitro Expressed in a Transcription-Translation Cell-Free System by a Novel Conjugate Based on Cadmium Sulphide Nanoparticles
por: Barba-Vicente, Víctor, et al.
Publicado: (2020)

From Bench to Bedside: Immunotherapy for Prostate Cancer
por: Tse, Brian Wan-Chi, et al.
Publicado: (2014)

Cancer photo-immunotherapy: from bench to bedside
por: Wang, Miao, et al.
Publicado: (2021)

Immunotherapy for Recurrent Glioma—From Bench to Bedside
por: Pu, Yi, et al.
Publicado: (2023)

SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS
por: Juanes-Velasco, Pablo, et al.
Publicado: (2022)

Natural Killer Cell Immunotherapy: From Bench to Bedside
por: Domogala, Anna, et al.
Publicado: (2015)

Takotsubo Syndrome: From Bench to Bedside and Bedside to Bench
por: Pelliccia, Francesco, et al.
Publicado: (2022)

Bench and Bedside
por: Schmidt, Christian
Publicado: (2002)

Dynamic Intracellular Metabolic Cell Signaling Profiles During Ag-Dependent B-Cell Differentiation
por: Díez, Paula, et al.
Publicado: (2021)

Targeting gamma delta T cells for cancer immunotherapy: bench to bedside
por: Gogoi, Dimpu, et al.
Publicado: (2013)

CAR-NK cells for cancer immunotherapy: from bench to bedside
por: Zhang, Leisheng, et al.
Publicado: (2022)

From bench to bedside
por: Verdant, Colin L
Publicado: (2012)

Dendritic Cell-based Immunotherapy for Rheumatoid Arthritis: from Bench to Bedside
por: Ahmed, Md. Selim, et al.
Publicado: (2016)

From bench to bedside a comprehensive review of pancreatic cancer immunotherapy
por: Kunk, Paul R., et al.
Publicado: (2016)

Promising role for Gc-MAF in cancer immunotherapy: from bench to bedside
por: Saburi, Ehsan, et al.
Publicado: (2017)

Recent Development in NKT-Based Immunotherapy of Glioblastoma: From Bench to Bedside
por: Li, Yutao, et al.
Publicado: (2022)

Targeting 4-1BB for tumor immunotherapy from bench to bedside
por: Wang, Ya-Tao, et al.
Publicado: (2022)

CDG Therapies: From Bench to Bedside
por: Brasil, Sandra, et al.
Publicado: (2018)

Deciphering Biomarkers for Leptomeningeal Metastasis in Malignant Hemopathies (Lymphoma/Leukemia) Patients by Comprehensive Multipronged Proteomics Characterization of Cerebrospinal Fluid
por: Juanes-Velasco, Pablo, et al.
Publicado: (2022)

Sepsis: From Bench to Bedside
por: Silva, Eliézer, et al.
Publicado: (2008)

Sonochemotherapy: from bench to bedside
por: Lammertink, Bart H. A., et al.
Publicado: (2015)

Nutrition: From Bench to Bedside
por: Khan, Naim A., et al.
Publicado: (2016)

Linagliptin: from bench to bedside
por: Doupis, John
Publicado: (2014)

Pruritus: From the Bench to the Bedside
por: Reich, Adam, et al.
Publicado: (2018)

Silver linings at the bench and bedside
por: Katz, Steven C., et al.
Publicado: (2020)

Olutasidenib: from bench to bedside
por: Venugopal, Sangeetha, et al.
Publicado: (2023)

Metformin and Cancer Glucose Metabolism: At the Bench or at the Bedside?
por: Marini, Cecilia, et al.
Publicado: (2021)

Bench-To-Bedside and Bedside Back to the Bench; Coordinating Clinical and Experimental Traumatic Brain Injury Studies
por: Agoston, Denes V., et al.
Publicado: (2012)

Development of Pharmaceutical Nanomedicines: From the Bench to the Market
por: Halwani, Abdulrahman A.
Publicado: (2022)

Immunotherapy for the Prevention and Treatment of Type 1 Diabetes: Optimizing the path from bench to bedside
por: Bresson, Damien, et al.
Publicado: (2009)

Predicting response to immunotherapy in non-small cell lung cancer- from bench to bedside
por: Montoya, Chris, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_63krfgcvdnoqdrder0c4prgloi